Catalyst Funds Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,151
Closed -$121K 534
2025
Q2
$121K Buy
+12,151
New +$128K 0.03% 339
2024
Q4
Sell
-8,800
Closed -$98K 596
2024
Q3
$98K Buy
8,800
+2,200
+33% +$24.3K 0.02% 513
2024
Q2
$74.1K Buy
+6,600
New +$76.8K 0.02% 346

Other funds holding DVAX

Catalyst Funds Management's DVAX Position: Q3 2025 in Review

Catalyst Funds Management sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 12,151 shares — an estimated $121K sold.

Catalyst Funds Management first reported a position in DVAX in Q2 2024 and held it in 3 quarters. The position peaked at $121K in Q2 2025. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • Catalyst Funds Management reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 12,151 Dynavax Technologies shares in Q3 2025, an estimated $121K.
  • Catalyst Funds Management first reported a position in Dynavax Technologies in Q2 2024 and held it in 3 quarters.
  • Catalyst Funds Management's Dynavax Technologies position peaked at $121K in Q2 2025.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on Catalyst Funds Management's 13F filing for Q3 2025, filed 12 Nov 2025.